Data / Form D filings / Natsar Pharmaceuticals, Inc.
Natsar Pharmaceuticals, Inc.: Form D filing
Natsar Pharmaceuticals, Inc., a pharmaceuticals company in Ellicott City, MD, filed a Form D with the SEC in 2026. The latest, on May 8, 2026, reports $4.2 million sold of an offering with no set size to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4624 TALL MAPLE CT., Ellicott City, MD, 21043
- Phone
- (410) 948-2578
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2134002
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | New notice | Indefinite | $4,221,000 | 15 | Apr 23, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Venu Raman | Executive Officer, Director |
Other pharmaceuticals companies in Maryland that filed recently
- Cerium Pharmaceuticals, Inc. $750,000 · Aug 6, 2026
Every Form D from the week of May 4, 2026 · All recent filings in Maryland · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Natsar Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.